All Stories

  1. Anticancer drug nanomicelles formed by self-assembling amphiphilic dendrimer to combat cancer drug resistance
  2. Cationic carbosilane dendrimers and oligonucleotide binding: an energetic affair
  3. A step forward in the sigma enigma: a role for chirality in the sigma1 receptor–ligand interaction?
  4. Improving selectivity preserving affinity: New piperidine-4-carboxamide derivatives as effective sigma-1-ligands
  5. Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinoma
  6. Adaptive Amphiphilic Dendrimer-Based Nanoassemblies as Robust and Versatile siRNA Delivery Systems
  7. Adaptive Amphiphilic Dendrimer-Based Nanoassemblies as Robust and Versatile siRNA Delivery Systems
  8. Identification, pharmacological evaluation and binding mode analysis of novel chromene and chromane based σ1 receptor ligands
  9. Shape-Persistent and Adaptive Multivalency: Rigid Transgeden (TGD) and Flexible PAMAM Dendrimers for Heparin Binding
  10. The Sigma Enigma: In Vitro / in Silico Site-Directed Mutagenesis Studies Unveil σ 1 Receptor Ligand Binding
  11. Synthesis, Pharmacological Evaluation, and σ 1 Receptor Interaction Analysis of Hydroxyethyl Substituted Piperazines
  12. Combination of Dendrimer-Nanovector-Mediated Small Interfering RNA Delivery to Target Akt with the Clinical Anticancer Drug Paclitaxel for Effective and Potent Anticancer Activity in Treating Ovarian Cancer
  13. Molecular dynamics reveal BCR-ABL1 polymutants as a unique mechanism of resistance to PAN-BCR-ABL1 kinase inhibitor therapy
  14. Synthesis and receptor binding studies of some new arylcarboxamide derivatives as sigma-1 ligands
  15. Copper(ii) binding to flexible triethanolamine-core PAMAM dendrimers: a combined experimental/in silico approach
  16. Double-degradable responsive self-assembled multivalent arrays – temporary nanoscale recognition between dendrons and DNA
  17. Nanoscale self-assembled multivalent (SAMul) heparin binders in highly competitive, biologically relevant, aqueous media
  18. Mimicking the 2-oxoglutaric acid signalling function using molecular probes: insights from structural and functional investigations
  19. Modelling and Simulation of Sol-Gel Nanocomposites
  20. Conformational sensitivity of conjugated poly(ethylene oxide)-poly(amidoamine) molecules to cations adducted upon electrospray ionization – A mass spectrometry, ion mobility and molecular modeling study
  21. Structure of the σ 1 Receptor and Its Ligand Binding Site
  22. Conformational changes of small PAMAM dendrimers as a function of their charge state: A combined electrospray mass spectrometry, traveling-wave ion mobility and molecular modeling study
  23. Abstract C180: Novel small molecule inhibitors of signal transducer and activator of transcription (STAT3) for cancer treatment.
  24. Abstract B277: Polymutant BCR-ABL1 proteins during chronic myeloid leukemia therapy: Novel mechanisms of resitance from clinical, in vitro, and in silico evidence.
  25. Abstract PR05: Resistance to Hedgehog inhibitor through Smoothened receptor mutation in basal cell carcinoma.
  26. Complexes between Poly(amido amine) Dendrimers and Poly(methacrlyic acid): Insight from Molecular Dynamics Simulations
  27. Structural Requirements of 2-Oxoglutaric Acid Analogues To Mimic Its Signaling Function
  28. In vitro and in silico studies of MDM2/MDMX isoforms predict Nutlin-3A sensitivity in well/de-differentiated liposarcomas
  29. Impact of siRNA Overhangs for Dendrimer-Mediated siRNA Delivery and Gene Silencing
  30. Nano tools for macro problems: multiscale molecular modeling of nanostructured polymer systems
  31. Chemical, Pharmacological, and in vitro Metabolic Stability Studies on Enantiomerically Pure RC‐33 Compounds: Promising Neuroprotective Agents Acting as σ 1 Receptor Agonists
  32. Through the open door: Preferential binding of dasatinib to the active form of BCR-ABL unveiled by in silico experiments
  33. From Multivalent Dendrons to Self‐asssembled Multivalent Dendrimers: a Combined Experimental and Theoretical Approach
  34. Poly(Aminoester) Dendrimers: Design, Synthesis and Characterization
  35. Poly(amidoamine) (Pamam) Dendrimers as Non‐viral Vectors for the Delivery of RNA Therapeutics
  36. Multiscale Modeling of Dendrimers and Dendrons for Drug and Nucleic Acid Delivery
  37. Analysis of the molecular interactions of the potent analgesic S1RA with the σ1 receptor
  38. Identification of RC-33 as a potent and selective σ1 receptor agonist potentiating NGF-induced neurite outgrowth in PC12 cells. Part 2: g-Scale synthesis, physicochemical characterization and in vitro metabolic stability
  39. Identification of Peptides with ELAV-like mRNA-Stabilizing Effect: An IntegratedIn Vitro/In SilicoApproach
  40. Are two better than one? A novel double-mutant KIT in GIST that responds to Imatinib
  41. Mallard Blue: A High-Affinity Selective Heparin Sensor That Operates in Highly Competitive Media
  42. Multiscale Modeling Approach for Polymeric Nanocomposites
  43. A simple new competition assay for heparin binding in serum applied to multivalent PAMAM dendrimers
  44. Self-assembled multivalent RGD-peptide arrays – morphological control and integrin binding
  45. Modeling hierarchically structured nanoparticle/diblock copolymer systems
  46. Another Brick in the Wall. Validation of the σ 1 Receptor 3D Model by Computer-Assisted Design, Synthesis, and Activity of New σ 1 Ligands
  47. Tell Me Something I Do Not Know. Multiscale Molecular Modeling of Dendrimer/ Dendron Organization and Self-Assembly In Gene Therapy
  48. Pd-Catalyzed Direct C–H Bond Functionalization of Spirocyclic σ 1 Ligands: Generation of a Pharmacophore Model and Analysis of the Reverse Binding Mode by Docking into a 3D Homology Model of the σ 1 Receptor
  49. Self-Organization of Mixtures of Fluorocarbon and Hydrocarbon Amphiphilic Thiolates on the Surface of Gold Nanoparticles
  50. Simple, Fast, and Accurate In silico Estimations of Contact Angle, Surface Tension, and Work of Adhesion of Water and Oil Nanodroplets on Amorphous Polypropylene Surfaces
  51. Efficient Delivery of Sticky siRNA and Potent Gene Silencing in a Prostate Cancer Model Using a Generation 5 Triethanolamine-Core PAMAM Dendrimer
  52. Rationalizing the F⋯S interaction discovered within a tetrafluorophenylazido-containing bola-phospholipid
  53. Size and shape matter! A multiscale molecular simulation approach to polymer nanocomposites
  54. Structurally Flexible Triethanolamine Core PAMAM Dendrimers Are Effective Nanovectors for DNA Transfection in Vitro and in Vivo to the Mouse Thymus
  55. Degradable Self-Assembling Dendrons for Gene Delivery: Experimental and Theoretical Insights into the Barriers to Cellular Uptake
  56. Poly(amidoamine)-based Dendrimer/siRNA Complexation Studied by Computer Simulations: Effects of pH and Generation on Dendrimer Structure and siRNA Binding
  57. Homology Model and Docking-Based Virtual Screening for Ligands of the σ 1 Receptor
  58. MULTISCALE MODELING OF POLYMER/CLAY NANOCOMPOSITES
  59. 3-Aryl-2-[1H-benzotriazol-1-yl]acrylonitriles: A novel class of potent tubulin inhibitors
  60. The rise and fall of gatekeeper mutations? TheBCR-ABL1T315I paradigm
  61. 2-Difluoromethylene-4-methylenepentanoic Acid, A Paradoxical Probe Able To Mimic the Signaling Role of 2-Oxoglutaric Acid in Cyanobacteria
  62. Hydrophobically Modified Dendrons: Developing Structure−Activity Relationships for DNA Binding and Gene Transfection
  63. Targeted therapy in GIST: in silico modeling for prediction of resistance
  64. Sodium montmorillonite silylation: Unexpected effect of the aminosilane chain length
  65. Synergistic experimental/computational studies on arylazoenamine derivatives that target the bovine viral diarrhea virus RNA-dependent RNA polymerase
  66. PAMAM Dendrimers for siRNA Delivery: Computational and Experimental Insights
  67. A 3D-pharmacophore model for σ2 receptors based on a series of substituted benzo[d]oxazol-2(3H)-one derivatives
  68. Imatinib response in two GIST patients carrying two hitherto functionally uncharacterized PDGFRA mutations: An imaging, biochemical and molecular modeling study
  69. Quantifying the Effect of Surface Ligands on Dendron-DNA Interactions: Insights into Multivalency through a Combined Experimental and Theoretical Approach
  70. Antiviral activity of benzimidazole derivatives. II. Antiviral activity of 2-phenylbenzimidazole derivatives
  71. Pharmacophore modeling, resistant mutant isolation, docking, and MM-PBSA analysis: Combined experimental/computer-assisted approaches to identify new inhibitors of the bovine viral diarrhea virus (BVDV)
  72. Less is more – multiscale modelling of self-assembling multivalency and its impact on DNA binding and gene delivery
  73. Morphology prediction of block copolymers for drug delivery by mesoscale simulations
  74. A molecular simulation approach to the prediction of the morphology of self-assembled nanoparticles in diblock copolymers
  75. Activity and molecular modeling of a new small molecule active against NNRTI-resistant HIV-1 mutants
  76. Multiscale Computer Simulation Studies of Water-Based Montmorillonite/Poly(ethylene oxide) Nanocomposites
  77. Targeted Therapies: The Rare Cancer Paradigm
  78. Multiscale molecular modeling in nanostructured material design and process system engineering
  79. Synthesis, Biological Evaluation, and Three-Dimensional in Silico Pharmacophore Model for σ 1 Receptor Ligands Based on a Series of Substituted Benzo[ d ]oxazol-2(3 H )-one Derivatives
  80. Activate and resist: L576P-KIT in GIST
  81. 113 Molecular modelling of KIT and PDGRA mutant forms to predict sensitivity to new drugs in GISTs
  82. A Complete Multiscale Modelling Approach for Polymer-Clay Nanocomposites
  83. Modeling the Multivalent Recognition between Dendritic Molecules and DNA: Understanding How Ligand “Sacrifice” and Screening Can Enhance Binding
  84. Antimycobacterial activity of new 3,5-disubstituted 1,3,4-oxadiazol-2(3H)-one derivatives. Molecular modeling investigations
  85. Antiviral and cytotoxic activities of aminoarylazo compounds and aryltriazene derivatives
  86. T670X KIT Mutations in Gastrointestinal Stromal Tumors: Making Sense of Missense
  87. Technologies at Hand: Quo vadis, affinity? Clinical evidences and computer-assisted simulations in the Imatinib saga
  88. Hydrogen sulfide removal from biogas by zeolite adsorption. Part II. MD simulations
  89. Hydrogen sulphide removal from biogas by zeolite adsorptionPart I. GCMC molecular simulations
  90. 484 POSTER EGFR mutations and gefitinib affinity: molecular insights from in silico experiments
  91. 550 POSTER Designing nanovectors for siRNA delivery: coupled experimental/modeling investigations
  92. Base Invaders. Coupling Experiments and Multiscale Modeling of Dendrimer-Based siRNA Delivery Agents
  93. Multiscale Molecular Modeling of Hybrid Organic-Inorganic Nanocomposites of Type I and II
  94. Scripting approach in hybrid organic–inorganic condensation simulation: the GPTMS proof-of-concept
  95. Base Invaders. Coupling Experiments and Multiscale Modeling of Dendrimer-Based siRNA Delivery Agents
  96. Antimicrobial and cytotoxic arylazoenamines. Part III: Antiviral activity of selected classes of arylazoenamines
  97. Self-Assembly of Nanoparticle Mixtures in Diblock Copolymers: Multiscale Molecular Modeling
  98. Unlucky number 13? Differential effects of KIT exon 13 mutation in gastrointestinal stromal tumors
  99. 2(3)-Aryl-thio(oxy)-methylquinoxaline Derivatives: A New Class of P-Glycoprotein-Mediated Drug Efflux Inhibitors
  100. Activity of Mannich bases of 7-hydroxycoumarin against Flaviviridae
  101. Many-scale molecular simulation for ABS–MMT nanocomposites: Upgrading of industrial scraps
  102. Design, Synthesis and Anti Flaviviridae Activity of N6-, 5′,3′-O- and 5′,2′-O-Substituted Adenine Nucleoside Analogs
  103. To the nanoscale, and beyond!
  104. Synthesis, antifungal and antimycobacterial activities of new bis-imidazole derivatives, and prediction of their binding to P45014DM by molecular docking and MM/PBSA method
  105. Synthesis and Anti-Picornaviridae In Vitro Activity of a New Class of Helicase Inhibitors the N,N-bis[4-(1H(2H)-benzotriazol-1(2)-yl)phenyl] alkyldicarboxamides
  106. Polymer−Clay Nanocomposites:  A Multiscale Molecular Modeling Approach
  107. Binding at the Core. Computational Study of Structural and Ligand Binding Properties of Naphthyridine-Based Dendrimers
  108. Design, synthesis, and preliminary in vitro and in silico antiviral activity of [4,7]phenantrolines and 1-oxo-1,4-dihydro-[4,7]phenantrolines against single-stranded positive-sense RNA genome viruses
  109. Multiscale modeling for polymer systems of industrial interest
  110. Grand Canonical Monte-Carlo simulations for VOCs adsorption in non-polar zeolites
  111. Chloroform sorption in nanoporous crystalline and amorphous phases of syndiotactic polystyrene
  112. Synthesis and In Vitro Evaluation of the Anti-Viral Activity of N-[4-(1H(2H)-benzotriazol-1(2)-yl)phenyl]alkylcarboxamides
  113. 219 POSTER Equilibrium on hold. A computational rationale for the role of kit juxtamembrane mutations in controlling receptor autophosphorylation
  114. Re: Response of a KIT-Positive Extra-abdominal Fibromatosis to Imatinib Mesylate and KIT Genetic Analysis
  115. Many-Scale Simulation of ABS/PC Blends for the Automotive Industry
  116. Release of Proteins from Nanochannel Delivery Systems: A Coupled Many-Scale Simulation - Experimental Investigation
  117. Release of Proteins from Nanochannel Delivery Systems: A Coupled Many-Scale Simulation - Experimental Investigation
  118. Many-Scale Simulation of ABS/PC Blends for the Automotive Industry
  119. Multiscale modeling of protein transport in silicon membrane nanochannels. Part 2. From molecular parameters to a predictive continuum diffusion model
  120. Multiscale modeling of protein transport in silicon membrane nanochannels. Part 1. Derivation of molecular parameters from computer simulations
  121. In Silico Prediction of Medium Effects on Esterification Equilibrium Using the COSMO-RS Method
  122. PET/PEN blends of industrial interest as barrier materials. Part I. Many-scale molecular modeling of PET/PEN blends
  123. Functional analyses and molecular modeling of two c-Kit mutations responsible for imatinib secondary resistance in GIST patients
  124. Structure and Energetics of Biocompatible Polymer Nanocomposite Systems:  A Molecular Dynamics Study
  125. Simple but Highly Effective Three-Dimensional Chemical-Feature-Based Pharmacophore Model for Diketo Acid Derivatives as Hepatitis C Virus RNA-Dependent RNA Polymerase Inhibitors
  126. T315I-mutated Bcr-Abl in chronic myeloid leukemia and imatinib: insights from a computational study
  127. Antimycobacterial activity of new 3-substituted 5-(pyridin-4-yl)-3H-1,3,4-oxadiazol-2-one and 2-thione derivatives. Preliminary molecular modeling investigations
  128. Process Simulation for Molten Carbonate Fuel Cells
  129. Computer simulation of polypropylene/organoclay nanocomposites: characterization of atomic scale structure and prediction of binding energy
  130. 619 Analogies in imatinib-resistant threonine-to-isoleucine mutation in BCR-ABL, KIT and PDGFRa: a combined experimental/computational approach
  131. Polyamidoamine (Yet Not PAMAM) Dendrimers as Bioinspired Materials for Drug Delivery:  Structure−Activity Relationships by Molecular Simulations †
  132. Estimation of the Binding Energy in Random Poly(Butylene terephtalate-co-thiodiethylene terephtalate) Copolyesters/Clay Nanocomposites via Molecular Simulation
  133. Structure-based design of inhibitors of NS3 serine protease of hepatitis C virus
  134. Hindered nucleoside analogs as antiflaviviridae agents
  135. Atomistic molecular dynamics simulations of gas diffusion and solubility in rubbery amorphous hydrocarbon polymers
  136. Studying enzyme enantioselectivity using combined ab initio and free energy calculations: α-chymotrypsin and methyl cis- and trans-5-oxo-2-pentylpirrolidine-3-carboxylates
  137. Computer simulation of nylon-6/organoclay nanocomposites: prediction of the binding energy
  138. Synthesis and Physicochemical Characterization of Folate−Cyclodextrin Bioconjugate for Active Drug Delivery
  139. Development of an all-atoms force field from ab initio calculations for alternative refrigerants
  140. Host–guest inclusion complexes between anticancer drugs and β-cyclodextrin: computational studies
  141. Scaling properties in the molecular structure of three-dimensional, nanosized phenylene-based dendrimers as studied by atomistic molecular dynamics simulations
  142. Chemo-Enzymatic Synthesis and Determination of the Absolute Configuration of Both Enantiomers of Methyl trans-5-Oxo-2-pentylpyrrolidine-3-carboxylate Precursors of the Aza Analogues of (+)- and (−)-Methylenolactocin
  143. Prediction of thermophysical properties of alternative refrigerants by computational chemistry
  144. Computational studies on the enantioselectivity of α-chymotrypsin towards β-carbomethoxy-γ-lactams
  145. A chemoenzymatic approach to the synthesis of enantiomerically pure aza analogues of paraconic acid methyl ester and both enantiomers of methyl β-proline
  146. Prediction of phase equilibria for binary mixtures by molecular modeling
  147. Molecular simulation of host–guest inclusion compounds: an approach to the lactodendrimers case
  148. Virtual rheological experiments on linear alkane chains confined between titanium walls
  149. Clear and pigmented water epoxy systems: a study on the hardening kinetics on the basis of the variations of the viscoelastic moduli
  150. Dendrimers as Functional Materials. A Molecular Simulation Study of Poly(propylene) Imine Starburst Molecules
  151. From Molecular to Process Simulation: Novel Approaches to the Prediction of Phase Equilibria and PVT Behavior Based on Molecular/Quantum Mechanics and Molecular Dynamics Simulations
  152. A novel approach to thermophysical properties prediction for chloro-fluoro-hydrocarbons
  153. Equation-of-state parameters for pure polymers by molecular dynamics simulations
  154. Molecular dynamics simulations of real systems: application to chloro-fluoro-hydrocarbons and polymers
  155. THE EFFECT OF DRUG DISSOLUTION ON DRUG RELEASE FROM SWELLING POLYMERIC MATRICES: MATHEMATICAL MODELING
  156. Viscoelastic properties of solder pastes
  157. MODELING OF DRUG RELEASE FROM A SWELLABLE MATRIX
  158. Viscoelastic Properties of Welan Systems
  159. Viscosity of Aqueous Suspensions of Binary And Ternary Alumina Mixtures
  160. Determination of the drug diffusion coefficient in swollen hydrogel polymeric matrices by means of the inverse sectioning method
  161. APPARENT NON-FICKIAN RELEASE FROM A SCLEROGLUCAN GEL MATRIX
  162. Rheological modeling of fractal and dense suspensions
  163. Controlled release of theophylline from water-swollen scleroglucan matrices
  164. Modeling phase transitions and sorption desorption kinetics in thermo-sensitive gels for controlled drug delivery systems
  165. Flow properties of hydroxypropyl guar gum and its long-chain hydrophobic derivatives
  166. Rheology of Industrial Polysaccharides: Theory and Applications
  167. Rheological behaviour of low-fat and full-fat stirred yoghurt
  168. Carboxymethyl starch: A rheological study
  169. Continuous and oscillatory flow properties of concentrated coal/water suspensions
  170. Rheology of culture broths and exopolysaccharide of Cyanospira capsulata at different stages of growth
  171. Different behaviors of concentrated polysaccharide systems in large-amplitude oscillating shear fields
  172. LONG-CHAIN HYDROPHOBIC DERIVATIVES OF HYDROXYPROPYL GUAR GUM (HPG): A RHEOLOGICAL STUDY IN SHEAR CONDITIONS
  173. Rheology of hydroxyethyl guar gum derivatives
  174. Flow properties of N-(carboxymethyl) chitosan aqueous systems in the sol and gel domains
  175. Rheology of Filled Scleroglucan Gels
  176. Novel rheological model for the gelation kinetics of ionic polysaccharides
  177. Rheological properties of polysaccharide solutions and derived printing pastes in continuous and oscillatory flow conditions
  178. Multiscale Molecular Modelling of Dispersion of Nanoparticles in Polymer Systems of Industrial Interest